Results of the international multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of the sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (MIR)

Shamalov, N.A.; Fedin, A.I.; Rakhimbaeva, G.S.; Nurguzhaev, E.S.; Khasanova, D.R.; Solovyova, E.Yu.; Melnikova, E.V.; Yanishevsky, S.N.; Mashin, V.V.; Pizova, N.V.; Poverennova, I.E.; Chuprina, S.E.; Agafina, A.S.; Roshkovskaya, L.V.

doi:10.17116/jnevro202512508240

Public

Results of the international multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of the sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (MIR)

Shared by NobleBlocks on Sep 3, 2025 • 12:00 AM UTC

Authors:

N.A. Shamalov

A.I. Fedin

G.S. Rakhimbaeva

Abstract

Objective. Evaluation of the comparative efficacy and safety of ethylmethylhydroxypyridine succinate therapy with Mexidol, solution for intravenous and intramuscular administration, 50 mg/ml, and Mexidol FORTE 250, film-coated tablets, 250 mg, during their sequential use in patients in the acute and...

Discussions